These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 26262418)
1. Knowledge-based immunosuppressive therapy for kidney transplant patients--from theoretical model to clinical integration. Seeling W; Plischke M; de Bruin JS; Schuh C Stud Health Technol Inform; 2015; 216():1119. PubMed ID: 26262418 [TBL] [Abstract][Full Text] [Related]
2. Knowledge-based tacrolimus therapy for kidney transplant patients. Seeling W; Plischke M; Schuh C Stud Health Technol Inform; 2012; 180():310-4. PubMed ID: 22874202 [TBL] [Abstract][Full Text] [Related]
3. Clinical decision support systems at the Vienna General Hospital using Arden Syntax: Design, implementation, and integration. Schuh C; de Bruin JS; Seeling W Artif Intell Med; 2018 Nov; 92():24-33. PubMed ID: 26706047 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients. Kuypers DR Clin Pharmacol Ther; 2010 Nov; 88(5):595-6; author reply 597. PubMed ID: 20664539 [No Abstract] [Full Text] [Related]
5. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Jung HY; Seong SJ; Choi JY; Cho JH; Park SH; Kim CD; Yoon YR; Kim HK; Huh S; Yoon SH; Lee JS; Kim YL Trials; 2017 Oct; 18(1):480. PubMed ID: 29037222 [TBL] [Abstract][Full Text] [Related]
6. Dosing tacrolimus based on CYP3A5 genotype: will it improve clinical outcome? van Gelder T; Hesselink DA Clin Pharmacol Ther; 2010 Jun; 87(6):640-1. PubMed ID: 20485320 [TBL] [Abstract][Full Text] [Related]
7. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk. Lee J; Lee JJ; Kim BS; Lee JG; Huh KH; Park Y; Kim YS J Korean Med Sci; 2015 Jun; 30(6):682-7. PubMed ID: 26028917 [TBL] [Abstract][Full Text] [Related]
8. Treatment satisfaction in renal transplant patients taking tacrolimus once daily. van Boekel GA; Kerkhofs CH; Hilbrands LB Clin Ther; 2013 Nov; 35(11):1821-9.e1. PubMed ID: 24135441 [TBL] [Abstract][Full Text] [Related]
9. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683 [TBL] [Abstract][Full Text] [Related]
10. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? Hanto DW; Chudzinski R Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968 [No Abstract] [Full Text] [Related]
11. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant. Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086 [TBL] [Abstract][Full Text] [Related]
12. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Peng Y; Ke M; Xu L; Liu L; Chen X; Xia W; Li X; Chen Z; Ma J; Liao D; Li G; Fang J; Pan G; Xiang AP Transplantation; 2013 Jan; 95(1):161-8. PubMed ID: 23263506 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in kidney transplantation. Kliem V; Brunkhorst R Contrib Nephrol; 1998; 124():103-16; discussion 116-25. PubMed ID: 9761977 [No Abstract] [Full Text] [Related]
14. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718 [TBL] [Abstract][Full Text] [Related]
15. Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection. Dave V; Mulley W; Kanellis J; Summers S Nephrology (Carlton); 2015 Mar; 20 Suppl 1():2-5. PubMed ID: 25807849 [TBL] [Abstract][Full Text] [Related]
16. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients. Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594 [TBL] [Abstract][Full Text] [Related]
18. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. Calia R; Lai C; Aceto P; Luciani M; Romagnoli J; Lai S; Gargiulo A; Citterio F Transplant Proc; 2011 May; 43(4):1020-3. PubMed ID: 21620041 [TBL] [Abstract][Full Text] [Related]
19. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients. Chadban S Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882 [No Abstract] [Full Text] [Related]
20. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies. Graham F; Racicot F; Jamali L; Cong VP; Raboisson MJ; Paradis J; Paradis L; Des Roches A Ann Allergy Asthma Immunol; 2015 Aug; 115(2):155-7. PubMed ID: 26094803 [No Abstract] [Full Text] [Related] [Next] [New Search]